Published in Cancer on October 01, 1987
Assessing prevention effectiveness using data to drive program decisions. Public Health Rep (1994) 1.03
Breast cancer risk and participation in mammographic screening. Am J Public Health (1989) 1.03
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med (2000) 3.62
Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem (1994) 3.14
The evaluation of continuing medical education: a literature review. Health Educ Monogr (1977) 2.80
Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res (1998) 2.35
Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science (1979) 2.22
Measuring severity of illness: homogeneous case mix groups. Med Care (1983) 1.99
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
The new medical practice environment. Internists' view of the future. Arch Intern Med (1989) 1.84
Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem (1980) 1.73
Innovative materials processing strategies: a biomimetic approach. Science (1992) 1.72
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem (1999) 1.62
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol (1994) 1.51
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J Virol (1994) 1.45
An X Window system for statlab results reporting. Proc Annu Symp Comput Appl Med Care (1993) 1.43
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther (2001) 1.41
Some thoughts on the nature of ectopic parathyroid hormones. Am J Med (1971) 1.39
Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Ther (2007) 1.37
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther (1998) 1.36
Hospital case mix groupings and generic algorithms. QRB Qual Rev Bull (1982) 1.30
In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest (1969) 1.26
HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene Ther (2007) 1.22
Biomineralization and eggshells: cell-mediated acellular compartments of mineralized extracellular matrix. Int Rev Cytol (1993) 1.22
Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol (1995) 1.22
Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J Virol (2000) 1.20
Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci U S A (1996) 1.12
Serum cholesterol and primary brain tumours: a case-control study. Int J Epidemiol (1989) 1.11
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther (1998) 1.08
Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther (1997) 1.06
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J Virol (1996) 1.06
Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia (2007) 1.05
Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000). J Clin Endocrinol Metab (2006) 1.01
Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. PCR Methods Appl (1994) 0.98
Differential distribution of (Na, K)-ATPase alpha isoforms in the central nervous system. Cell Mol Neurobiol (1991) 0.97
Engineering herpes simplex virus vectors for CNS applications. Exp Neurol (1999) 0.97
S100 is preferentially distributed in myelin-forming Schwann cells. J Neurocytol (1990) 0.97
HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J Neurovirol (2001) 0.95
A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther (2009) 0.95
Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol (1999) 0.95
Intermolecular interactions in collagen self-assembly as revealed by Fourier transform infrared spectroscopy. Science (1983) 0.94
Gene therapy progress and prospects: Parkinson's disease. Gene Ther (2003) 0.93
Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates. J Clin Microbiol (1987) 0.93
Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp Neurol (2001) 0.92
Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol (1990) 0.92
Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier. J Neurocytol (1992) 0.92
Cytochemical localization of Ca2+-ATPase activity in peripheral nerve. Brain Res (1988) 0.92
Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc Natl Acad Sci U S A (1999) 0.92
The avian eggshell extracellular matrix as a model for biomineralization. Connect Tissue Res (1996) 0.91
Immunocytochemical demonstration of Na+,K(+)-ATPase in internodal axolemma of myelinated fibers of rat sciatic and optic nerves. J Neurochem (1991) 0.91
MR imaging of brachial plexopathy in neurolymphomatosis. AJR Am J Roentgenol (1997) 0.89
Differential distribution of (Na,K)-ATPase alpha isoform mRNAs in the peripheral nervous system. Brain Res (1991) 0.88
Disease pattern recognition testing for rheumatoid arthritis using infrared spectra of human serum. Clin Chim Acta (2001) 0.88
Serum cholesterol levels in adenomatous polyps and cancer of the colon. A case-control study. JAMA (1986) 0.87
Cerebral atrophy in young cannabis smokers. Lancet (1972) 0.86
Changes in intra-axonal calcium distribution following nerve crush. J Neurobiol (1986) 0.86
Cancer overview. Cancer Res (1979) 0.85
Distribution of albumin-like immunoreactivity in rat sciatic nerve after nerve crush injury. J Neuropathol Exp Neurol (1988) 0.85
Retrograde axonal transport of endogenous proteins in sciatic nerve demonstrated by covalent labeling in vivo. Science (1980) 0.84
Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Ther (2011) 0.83
Ultrastructural distribution of Ca++ within neurons. An oxalate pyroantimonate study. Histochemistry (1987) 0.83
cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo. J Virol (1996) 0.83
Axotomy increases CNTF receptor mRNA in rat spinal cord. Brain Res (1993) 0.83
Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells (2001) 0.83
Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element. Gene Ther (2011) 0.82
The use of a labeled acylating probe for the study of fast axonal transport, in vivo. Brain Res (1979) 0.82
A direct electron microscopic immunocytochemical study of IgM paraproteinemic neuropathy. Arch Neurol (1988) 0.82
Routine chest x-ray films in a Veterans Hospital. JAMA (1981) 0.81
Herpes simplex virus vectors for gene transfer to the nervous system. J Neurovirol (1997) 0.81
The distribution of serum albumin in rat peripheral nerve. J Neuropathol Exp Neurol (1987) 0.81
Ca++-ATPase in the central nervous system: an EM cytochemical study. J Histochem Cytochem (1989) 0.80
Gene therapy for pain: introduction to the special issue. Gene Ther (2009) 0.80
Herpes simplex virus vectors and gene transfer to brain. Dev Biol Stand (1994) 0.80
Evidence for slow retrograde transport of serum albumin in rat sciatic nerve. Brain Res (1982) 0.79
Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Ther (1998) 0.79
Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion. Exp Neurol (2001) 0.78
Spectroscopic probes of blood-surface interaction. Trans Am Soc Artif Intern Organs (1983) 0.78
beta,beta'-Iminodipropionitrile impairs retrograde axonal transport. J Neurochem (1986) 0.78
Vector-mediated expression of erythropoietin improves functional outcome after cervical spinal cord contusion injury. Gene Ther (2011) 0.78
Gene transfer to brain using herpes simplex virus vectors. Ann Neurol (1994) 0.78
Axonal transport of proteins. A new view using in vivo covalent labeling. J Cell Biol (1980) 0.78
A new player in gene therapy for pain? Gene Ther (2008) 0.77
Engineering herpes simplex virus vectors for human gene therapy. Adv Pharmacol (1997) 0.77
Facts about colorectal cancer detection. CA Cancer J Clin (1984) 0.77
Formation of synaptic endings by colossal fibers in the vestibular epithelium of the chick embryo. Neuroscience (1977) 0.77
Modulation of phosphorylation of neuronal cytoskeletal proteins by neuronal depolarization. Cell Mol Neurobiol (1997) 0.77
Serum haptoglobin. A valuable diagnostic aid in suspected hemolytic transfusion reactions. JAMA (1967) 0.77
Activity-dependent regulation of Na+, K(+)-ATPase alpha isoform mRNA expression in vivo. J Neurochem (1992) 0.77
Refractory normoblastic ("sideroblastic") anemia. Clinical and electron microscopic observations. Am J Clin Pathol (1966) 0.76
Calmodulin distribution in peripheral nerve: an EM immunocytochemical study. Brain Res (1988) 0.76
An orally administered microcapsule system for treating chronic renal failure patients. Appl Biochem Biotechnol (1984) 0.76
Alterations in retrograde axonal transport in streptozocin-induced diabetic rats. Diabetes (1987) 0.76
Gene therapy for Canavan disease? Ann Neurol (2000) 0.75
Calpain II in rat peripheral nerve. Brain Res (1991) 0.75
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16. Gene Ther (1996) 0.75
HSV as a gene transfer vector for the nervous system. Mol Biotechnol (1995) 0.75
Development of herpes simplex virus as a gene transfer vector for the nervous system. Gene Ther (1994) 0.75
Crystallization studies on avian eggshell membranes: implications for the molecular factors controlling eggshell formation. Matrix Biol (1995) 0.75
Overproduction health professionals. N Engl J Med (1971) 0.75
6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study. Cancer Chemother Rep (1970) 0.75